TY - JOUR
T1 - A look into the future
T2 - Improving diabetes care by 2015
AU - Brunton, Stephen
AU - Gough, Stephen
AU - Hicks, Debbie
AU - Weng, Jianping
AU - Moghissi, Etie
AU - Peyrot, Mark
AU - Schneider, Doron
AU - Maria Schumm-Draeger, Petra
AU - Tobin, Christine
AU - Barnett, Anthony H.
N1 - Funding Information:
This paper represents the consensus opinion of a multidisciplinary team of experts in diabetes care who met in November 2010 to identify, discuss and put forward solutions to problems with insulin management in patients with diabetes. The meeting and medical writing assistance was organized and funded by Novo Nordisk.
PY - 2011/11
Y1 - 2011/11
N2 - Insulin initiation, which was traditionally the province of specialists, is increasingly undertaken by primary care. However, significant barriers to appropriate and timely initiation still exist. Whilst insulin is recognized as providing the most effective treatment in type 2 diabetes, it is also widely considered to be the most challenging and time consuming. This editorial identifies that the organization of existing healthcare services, the challenges faced by patients, and the treatments themselves contribute to suboptimal insulin management. In order to improve future diabetes care, it will be necessary to address all three problem areas: (1) re-think the best use of existing human and financial resources to promote and support patient self-management and adherence to treatment; (2) empower patients to participate more actively in treatment decision making; and (3) improve acceptance, persistence and adherence to therapy by continuing to refine insulin therapy and treatment regimens in terms of safety, simplicity and convenience. The principles discussed are also applicable to the successful management of any chronic medical illness.
AB - Insulin initiation, which was traditionally the province of specialists, is increasingly undertaken by primary care. However, significant barriers to appropriate and timely initiation still exist. Whilst insulin is recognized as providing the most effective treatment in type 2 diabetes, it is also widely considered to be the most challenging and time consuming. This editorial identifies that the organization of existing healthcare services, the challenges faced by patients, and the treatments themselves contribute to suboptimal insulin management. In order to improve future diabetes care, it will be necessary to address all three problem areas: (1) re-think the best use of existing human and financial resources to promote and support patient self-management and adherence to treatment; (2) empower patients to participate more actively in treatment decision making; and (3) improve acceptance, persistence and adherence to therapy by continuing to refine insulin therapy and treatment regimens in terms of safety, simplicity and convenience. The principles discussed are also applicable to the successful management of any chronic medical illness.
KW - Healthcare
KW - Insulin
KW - Non-adherence
KW - Oral antidiabetic drug
KW - Self-management
KW - Therapy adherence
KW - Type 2 diabetes mellitus
UR - http://www.scopus.com/inward/record.url?scp=81855206147&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=81855206147&partnerID=8YFLogxK
U2 - 10.1185/03007995.2011.603300
DO - 10.1185/03007995.2011.603300
M3 - Review article
C2 - 21781013
AN - SCOPUS:81855206147
VL - 27
SP - 65
EP - 72
JO - Current Medical Research and Opinion
JF - Current Medical Research and Opinion
SN - 0300-7995
IS - SUPPL. 3
ER -